Oxytocin and Interleukin-14: New suggested indicators for prediction of type 2 diabetes-induced nephropathy

Author:

Hasan Jasim Rasha1,Abbas Khulaibus Mohammed1

Affiliation:

1. Department of Chemistry, Faculty of Education for Girls, University of Kufa, Iraq

Abstract

Diabetes is one of the major risk factors for chronic renal failure (CRF). The present work involved studying the effect of lifestyle factors such as (age, gender, smoking and area of residence) which can affect chronic renal diseases. Also, the study estimated Oxytocin (Oxt) and Interleukin-14 (IL-14) using the sandwich ELISA technique in the serum of type 2 diabetic patients with CRF who presented to hemodialysis and a control group. Blood samples of (50) diagnosed type 2 diabetic patients with CRF from both sexes were compared with (40) samples from healthy individuals as a control group. The results demonstrated significant elevation (p<0.05) in Oxt and IL-14 concentrations for patients with CRF compared to the control group. As for the subgroups, the statistical test showed a significant difference (p < 0.05) when comparing Oxt levels between the same sex in the two groups. While no significant difference was observed when comparing IL-14 in the same or the two groups. The parameters Oxt and IL-14 are necessary tools for predicting renal failure. Keywords: Oxytocin, Interleukin-14, Type 2 Diabetes Mellitus, Hemodialysis

Publisher

Clinical Biotec

Subject

Infectious Diseases,Applied Microbiology and Biotechnology,Epidemiology,Biotechnology

Reference32 articles.

1. K. Umanath and J. B. Lewis, “Update on Diabetic Nephropathy: Core Curriculum,” Am. J. Kidney Dis.,

2. 2018; 71(6) 884–895, 2018, doi: 10.1053/j.ajkd.2017.10.026.

3. 2 D. J. Den Hartog and E. Tsiani, Health benefits of resveratrol in kidney disease: Evidence from in vitro

4. and in vivo studies, 2019; 11(7).

5. 3 K. C. Keri, N. S. Samji, and S. Blumenthal, “Diabetic nephropathy: newer therapeutic perspectives,” J.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3